Mega%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520cv

# MegaCV ## Overview MegaCV is a brand name for a combination product containing Vitamin C (ascorbic acid) and various forms of Vitamin E (tocopherols and tocotrienols). It is an antioxidant supplement. ## Primary Indications MegaCV is primarily used for the prevention and treatment of vitamin C and vitamin E deficiencies. It is also marketed for general antioxidant support, although robust clinical evidence for these uses is often limited. ## Adult Dosing Dosing varies significantly based on the specific product formulation and intended use. Always refer to the product's specific labeling. A common dosage range for general antioxidant supplementation might be 1-2 capsules daily, but this is not based on established therapeutic guidelines for specific conditions. ## Pediatric Dosing No specific pediatric dosing is established for MegaCV. Use in pediatric populations should be guided by a healthcare provider and based on individual need and product availability, if appropriate. ## Dose Adjustments No specific dose adjustments are typically required for renal or hepatic impairment. However, high doses of Vitamin C can increase the risk of oxalate nephropathy in patients with renal impairment. ## Contraindications * Hypersensitivity to any component of the formulation. * History of kidney stones (oxalate stones) when considering high doses of Vitamin C. * Certain conditions like hemochromatosis may warrant caution with high doses of Vitamin C, though this is not an absolute contraindication. ## Adverse Effects * **Vitamin C:** Diarrhea, nausea, abdominal cramps, heartburn. High doses can lead to oxalate kidney stones, and may interfere with certain laboratory tests (e.g., glucose monitoring). * **Vitamin E:** Nausea, diarrhea, fatigue, headache, dizziness, blurred vision. High doses have been associated with an increased risk of bleeding, especially in patients taking anticoagulants. ## Key Drug Interactions * **Vitamin C:** * Aluminum-containing antacids: May increase aluminum absorption. * Chemotherapy agents: Antioxidants may potentially interfere with the efficacy of some cytotoxic chemotherapies; consult oncology guidelines. * Estrogen: May increase estrogen levels. * Warfarin: High doses of Vitamin C may decrease the anticoagulant effect of warfarin. * **Vitamin E:** * Anticoagulants (e.g., warfarin, heparin): Increased risk of bleeding. * Antiplatelets (e.g., aspirin, clopidogrel): Increased risk of bleeding. * Orlistat: May decrease absorption of fat-soluble vitamins like Vitamin E. ## Monitoring * Monitor for gastrointestinal upset. * In patients with renal impairment receiving high-dose Vitamin C, monitor for signs of oxalate nephropathy. * In patients on anticoagulants taking high-dose Vitamin E, monitor INR closely. ## Clinical Pearls * MegaCV is a supplement and should not replace standard medical treatment for diagnosed conditions. * Absorption of Vitamin E can be enhanced when taken with fatty meals. * Excess Vitamin C is water-soluble and generally excreted in urine; however, very high doses can saturate renal pathways and increase oxalate excretion. *** **Disclaimer:** This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current official prescribing information and relevant literature for complete details and to verify dosing and safety information before initiating therapy. Dosing can vary based on specific patient factors and local protocols.